BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16729482)

  • 1. [Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy].
    Rodríguez Roldán JM; Lara Alvarez MA; López Martínez J; Díaz Abad R; Caballero Campo M; Del Nogal Sáez F
    Med Intensiva; 2006 Apr; 30(3):123-4. PubMed ID: 16729482
    [No Abstract]   [Full Text] [Related]  

  • 2. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
    Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
    Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
    Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
    Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible cardiogenic shock following 5-fluorouracil infusion.
    Ferté C; Gomez Roca C; Loriot Y; Bahleda R; Moldovan C; Cohen A; Izzedine H; Soria JC; Ederhy S
    Invest New Drugs; 2010 Aug; 28(4):531-3. PubMed ID: 19499187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity of 5-fluorouracil: ischemia or myocardial toxicity?].
    López Medrano F; Sánchez Muñoz A; Sánchez Sánchez V; Costa Pérez-Herrero JR
    Rev Clin Esp; 2001 Feb; 201(2):106-7. PubMed ID: 11345600
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reversible cardiogenic shock under 5-fluorouracil treatment].
    Bakouboula B; Morel O; Douchet MP; Chauvin M
    Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
    Y-Hassan S; Tornvall P; Törnerud M; Henareh L
    Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
    Tajik R; Saadat H; Taherkhani M; Movahed MR
    Am Heart Hosp J; 2010; 8(2):E111-2. PubMed ID: 21928176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiotoxicity of 5-fluorouracil].
    Teixeira L; Barry S; Debourdeau P; Cohen A; Tournigand C
    Bull Cancer; 2004 Nov; 91 Suppl 3():154-8. PubMed ID: 15899622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy.
    Endo A; Yoshida Y; Nakashima R; Takahashi N; Tanabe K
    Int Heart J; 2013; 54(6):417-20. PubMed ID: 24309454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of cardiogenic shock caused by capecitabine treatment.
    To AC; Looi KL; Damianovich D; Taylor GB; Sidebotham D; White HD
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):725-9. PubMed ID: 18813211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
    Lestuzzi C; Vaccher E; Talamini R; Lleshi A; Meneguzzo N; Viel E; Scalone S; Tartuferi L; Buonadonna A; Ejiofor L; Schmoll HJ
    Ann Oncol; 2014 May; 25(5):1059-64. PubMed ID: 24558023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for routine monitoring of cardiac function in patients receiving 5-fluorouracil infusion.
    Francis N
    Clin J Oncol Nurs; 2014 Jun; 18(3):360-2. PubMed ID: 24867118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].
    Grześk G; Orzałkiewicz Z; Polak G; Przybył R; Nartowicz E; Szadujkis-Szadurski L; Grabczewska Z
    Przegl Lek; 2003; 60(1):46-8. PubMed ID: 12884648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
    Steger F; Hautmann MG; Kölbl O
    Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
    Akpek G; Hartshorn KL
    Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of myocardial ischaemia induced by 5-fluorouracil.
    Görgülü S; Oğuz E; Zor A; Zor U; Gürdoğan M; Tezel T
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):259-61. PubMed ID: 12223336
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil induced acute heart failure.
    Rateesh S; Shekar K; Naidoo R; Mittal D; Bhaskar B
    Circ Heart Fail; 2015 Mar; 8(2):381-3. PubMed ID: 25783948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.